AXIM Biotechnologies's total assets for Q2 2024 were $3.73M, a decrease of -5.73% from the previous quarter. AXIM total liabilities were $13.26M for the fiscal quarter, a 16.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.